Skip to content
10-K

Annual Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-24-012404

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 1, 2024 1.04B sh
Stock Issued FY 2023 · Feb 16, 2023 2.43M sh
Stock Issued FY 2023 · Feb 15, 2022 7.4M sh
Shares Diluted FY 2023 · Dec 31, 2022 974.31M sh
Capex FY 2023 · Dec 31, 2022 $5.02K
Operating Cash Flow FY 2023 · Dec 31, 2022 −$1.89M
Cash And Equivalents FY 2023 · Dec 31, 2022 $3.86M
Current Liabilities FY 2023 · Dec 31, 2022 $8.07M
Total Liabilities FY 2023 · Dec 31, 2022 $8.09M
Current Assets FY 2023 · Dec 31, 2022 $3.98M
Total Assets FY 2023 · Dec 31, 2022 $4.57M
Eps Diluted FY 2023 · Dec 31, 2022 $0.00
Eps Basic FY 2023 · Dec 31, 2022 $0.00
Sga Expense FY 2023 · Dec 31, 2022 $825.46K
Rd Expense FY 2023 · Dec 31, 2022 $176.43K
Net Income FY 2023 · Dec 31, 2022 −$3.84M
Operating Income FY 2023 · Dec 31, 2022 −$2.12M
Stockholders Equity FY 2023 · Dec 31, 2021 −$5.3M